Patient-reported outcomes following accelerated vs. standard TMS with the H1 coil for major depression: A multisite randomized trial
Accelerated TMS with the H1 coil provides patient-perceived benefits comparable to standard treatment while delivering faster relief of depressive symptoms. ACC-iTBS may represent a time-efficient, patient-centered alternative that improves accessibility and satisfaction for individuals with MDD.
Authors
- Aswin Kumar Mudunuru
- Carlene McMillan
- Russ Voltin
- Owen S. Muir (ORCID: https://orcid.org/0000-0002-4003-338X)
- Ahava Stein
- Natanya Slomowitz
- Mallory Bates
- Aron Tendler (ORCID: https://orcid.org/0000-0001-8587-7335)
- Nancy I. Williams (ORCID: https://orcid.org/0000-0003-3690-6691)
- Yiftach Roth
- Samson Seplow
- Spencer Luce
- M.S. Reddy
- Colleen A. Hanlon
- Timothy Prestley
- Daniel M. Thistlethwaite
- Lindsey Jones
- Noelia Rodriguez
- Shelli Ellis
- Eliza Brink
- Molly Davis
- Aftab Khan
- Gabriel S. Pell
- Dawn DeBrocco
Institutions
- Ben-Gurion University of the Negev (IL)
- Lahey Hospital and Medical Center (US)
- University of Alabama (US)
- University of Washington (US)
- Radiall (France) (FR)
- Meir Medical Center (IL)
- Abington Memorial Hospital (US)
- Clear Science Corporation (United States) (US)
- Palm Beach Neurology (US)
- Iscare I.V.F (CZ)
- Western Digital (Israel) (IL)
- Radiant Research (United States) (US)
- Asha Hospital (IN)
- International Neuromodulation Society (US)
- Wake Forest University (US)
Publication Details
- Journal
- Brain stimulation
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1016/j.brs.2026.103048
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00